Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T19:46:19.418Z.
Calculation as of: 2026-10-06T19:46:19.418Z.
Quote observation: 2026-10-06T19:45:22.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 953d1456faf84e3d3f88a5480ffc5766df2e412b5fda6c1fb2fa7c75cf2e613b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Market Cap
$325.76M
EV/Sales Ratio
22.85x
TTM Avg
22.11x
3Y Avg
20.81x
5Y Avg
20.81x
Market Cap
$328.54M
EV/Sales Ratio
8.59x
TTM Avg
11.65x
3Y Avg
9.91x
5Y Avg
10.67x
Market Cap
$321.76M
EV/Sales Ratio
3.23x
TTM Avg
2.41x
3Y Avg
3.41x
5Y Avg
5.05x
Market Cap
$320.10M
EV/Sales Ratio
4.75x
TTM Avg
2.58x
3Y Avg
4.18x
5Y Avg
5.19x
Market Cap
$310.69M
EV/Sales Ratio
8.25x
TTM Avg
9.26x
3Y Avg
9.89x
5Y Avg
12.44x
Market Cap
$309.88M
EV/Sales Ratio
N/A
TTM Avg
727.13x
3Y Avg
2593.81x
5Y Avg
3058.46x
Market Cap
$346.14M
EV/Sales Ratio
N/A
TTM Avg
102877.97x
3Y Avg
102877.97x
5Y Avg
102877.97x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | $327.67M | N/A | N/A | N/A | N/A |
| CapsoVision, Inc. (CV)vs › | $325.76M | 22.85x | 22.11x | 20.81x | 20.81x |
| ClearPoint Neuro, Inc. (CLPT)vs › | $328.54M | 8.59x | 11.65x | 9.91x | 10.67x |
| Sanara MedTech Inc. (SMTI)vs › | $321.76M | 3.23x | 2.41x | 3.41x | 5.05x |
| Avita Medical Inc. (RCEL)vs › | $320.10M | 4.75x | 2.58x | 4.18x | 5.19x |
| Agenus Inc. (AGEN)vs › | $315.02M | 2.54x | 2.61x | 2.26x | 2.97x |
| C4 Therapeutics, Inc. (CCCC)vs › | $310.69M | 8.25x | 9.26x | 9.89x | 12.44x |
| Benitec Biopharma Inc. (BNTC)vs › | $309.88M | N/A | 727.13x | 2593.81x | 3058.46x |
| Relmada Therapeutics, Inc. (RLMD)vs › | $346.14M | N/A | 102877.97x | 102877.97x | 102877.97x |
| Turn Therapeutics Inc. (TTRX)vs › | $346.43M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
